fbpx

J Public Relations adds COVID-19 testing firm Genalyte to Health & Wellness Portfolio

by | Jun 22, 2020

Known internationally for their A-list client portfolio and award-winning media campaigns, J Public Relations (JPR) is expanding its well-being portfolio with the representation of Genalyte. The company’s rapid serology testing, backed by real-time diagnostics and analytics, has placed it at the forefront of COVID-19 antibody testing, paving the way forward in the fight against the novel coronavirus (SARS-CoV-2).

The state of the current global environment has encouraged companies to think more strategically about their skillset and how best to expand services in a thoughtful and strategic manner. As JPR continues to broaden its portfolio, Genalyte is an innovative company with an impactful tool to help find a solution to one of the biggest challenges in the world today. The company and its leadership have also taken on the responsibility of educating consumers about the important role of serology testing, in combination with diagnostic testing, to better understand COVID-19. The company’s rapid SARS-CoV-2 Multi-Antigen Serology Panel on its U.S. Food and Drug Administration (FDA)-cleared MaverickTMDiagnostic System tests for the detection of IgG and IgM antibodies that the body produces in response to the coronavirus.

“We’re proud to welcome such an innovative brand like Genalyte to our JPR family. To be able to tell such powerful stories during this time is extremely important to us and through our work with Genalyte, we’re able to deliver vital information to the community,” says Founding Partner Jamie Lynn O’Grady.

Genalyte’s Maverick instrument allows the company to deliver central lab-quality results in 20 minutes at decentralized testing locations. The high-quality, rapid testing provides immediate feedback to worried patients and helps employers make effective return-to-work decisions. The antibody test represents a crucial step in helping to develop an understanding of the virus, including how long antibodies stay in the body and if those with antibodies are less susceptible to reinfection.

The impacts of COVID-19 have paved the way for JPR to broaden its portfolio, building upon their first-class media relationships to strengthen brand awareness and bring important messages directly to a target consumer audience.

Daily PR Updates

Essential PR industry news, opinion, and analysis delivered to your inbox daily.

Bulldog Reporter
Bulldog Reporter is a leader in media intelligence supplying news, analysis and high-level training content to public relations and corporate communications professionals with the mission of helping these practitioners achieve superior competitive performance.

RECENT ARTICLES

How HR employee management software can improve your PR results

How HR employee management software can improve your PR results

The human resources and public relations departments are different sides of the same coin, but it’s rare that companies give them the space to work together. Without a quality work culture, employees will leave, talent will stay away, and your reputation will take a...

5 tips for PR to better incorporate technology

5 tips for PR to better incorporate technology

Technology has drastically changed the public relations field over the last several years. The rise of social media has given PR professionals new tools to reach and engage with their audiences. At the same time, new technologies have made it easier for journalists...